Month: December 2022

Evusheld Monoclonal Antibody Combination Now Available in Malaysia’s Private Market for Prevention of COVID-19 in High-Risk Individuals

AstraZeneca’s Evusheld (tixagevimab and cilgavimab, MAL 22056042ACR2), a monoclonal antibody combination, has been launched today in Malaysia’s private hospitals for...